Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.
FDA’s artificial intelligence is supposed to revolutionize drug approvals. It’s making up nonexistent studies.
